Syndax Pharmaceuticals Q4 EPS $(0.44) Beats $(0.49) Estimate, Sales $380.00K Beat $200.00K Estimate
Syndax Pharmaceuticals Q4 EPS $(0.44) Beats $(0.49) Estimate, Sales $380.00K Beat $200.00K Estimate
Syndax製藥第四季度每股收益0.44美元超過0.49美元預期,銷售額380.00K美元超過200.00K美元預期
Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.49) by 10.2 percent. This is unchanged from the same period last year. The company reported quarterly sales of $380.00 thousand which beat the analyst consensus estimate of $200.00 thousand by 90.00 percent. This is the same as the same period last year.
Syndax製藥公司(納斯達克:SNDX)公佈季度虧損(0.44美元),比分析師普遍預期的(0.49美元)高出10.2%。這與去年同期持平。該公司公佈季度銷售額為380萬美元,比分析師普遍預期的20萬美元高出90.00%。這與去年同期持平。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。